<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01249066</url>
  </required_header>
  <id_info>
    <org_study_id>DMR99-IRB-096</org_study_id>
    <nct_id>NCT01249066</nct_id>
  </id_info>
  <brief_title>Expression of AMP-activated Protein Kinase (AMPK) Protein in Lung Adenocarcinoma</brief_title>
  <official_title>Expression of AMP-activated Protein Kinase (AMPK) Protein in Lung Adenocarcinoma</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>China Medical University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>China Medical University Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      AMP-activated protein kinase (AMPK) is an evolutionally conserved protein kinase that serves
      as an energy guardian to help cells adapt to various metabolic stress including hypoxia.
      Because the role of AMPK in cancers has not been fully elucidated, in this study we
      investigated the expression and activation of AMPK in lung adenocarcinoma (LADC) cells and
      tissue.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>September 2010</start_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Lung Adenocarcinoma</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Lung cancer received lobectomy in CMUH
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Lung cancer received operation lobectomy in CMUH

        Exclusion Criteria:

          -  History of uremia, other malignant disease, and liver cirrhosis

          -  History of pneumonia and pulmonary tuberculosis

          -  History of long period of medications.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>25 Years</minimum_age>
    <maximum_age>85 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Fang Hsin Yuan</name>
      <address>
        <city>Taichung</city>
        <zip>404</zip>
        <country>Taiwan</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Hsin-Yuan Fang, MD</last_name>
      <phone>+886422052121</phone>
      <phone_ext>1638</phone_ext>
      <email>d93421104@ntu.edu.tw</email>
    </contact>
  </location>
  <location_countries>
    <country>Taiwan</country>
  </location_countries>
  <verification_date>September 2010</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 24, 2010</study_first_submitted>
  <study_first_submitted_qc>November 26, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 29, 2010</study_first_posted>
  <last_update_submitted>November 26, 2010</last_update_submitted>
  <last_update_submitted_qc>November 26, 2010</last_update_submitted_qc>
  <last_update_posted type="Estimate">November 29, 2010</last_update_posted>
  <responsible_party>
    <name_title>Fang Hsin-Yuan/Director</name_title>
    <organization>China Medical University Hospital</organization>
  </responsible_party>
  <keyword>AMP-activated protein kinase</keyword>
  <keyword>lung adenocarcinomas</keyword>
  <keyword>Prognosis</keyword>
  <keyword>Observation study</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Adenocarcinoma</mesh_term>
    <mesh_term>Lung Neoplasms</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

